Changes of demographic- and disease characteristics of patients with chronic HCV genotype 1 infection In Germany during the past decade
P Buggisch, H Löhr, G Teuber, H Steffens, M Kraus, C John, P Geyer, B Weber, T Witthöft, A Herrmann, M Hoesl, U Naumann, T Dahhan, D Hartmann, B Dreher, M Bilzer · Zeitschrift für Gastroenterologie · 2013 · Heft 08
Bibliografische Angaben
Zusammenfassung
Aims: In 2011, first generation HCV protease inhibitors combined with PegIFN and ribavirin (RBV) have been introduced as new standard of care for patients with chronic hepatitis C genotype 1 (G1) infection. We analyzed possible changes of demographic and disease characteristics of the German HCV-G1 population during the past decade which could influence the efficacy of novel HCV therapies in real-life. Methods: Data from 2226 G1-infected pts included in the German PegIFN2b/RBV observational study (Online-AWB) from 09/2003 to 05/2007 at 285 sites were retrospectively analyzed and compared with data from the ongoi…